Literature DB >> 14579249

Chronic activation of ERK and neurodegenerative diseases.

Luca Colucci-D'Amato1, Carla Perrone-Capano, Umberto di Porzio.   

Abstract

The extracellular-signal regulated kinases 1/2 (ERK or ERKs) are involved in the regulation of important neuronal functions, including neuronal plasticity in normal and pathological conditions. We present findings that support the notion that the kinetics and localization of ERK are intrinsically linked, in that the duration of ERK activation dictates its subcellular compartmentalization and/or trafficking. The latter, in turn, dictates whether ERK-expressing cells would enter a program of cell death, survival or differentiation. We summarize experimental data showing that chronic activation of ERK plays a role in the mechanisms that trigger neurodegeneration. We also discuss how MKPs, members of the subclass of dual specificity phosphatases, might be the link between ERK kinetics and its subcellular localization. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579249     DOI: 10.1002/bies.10355

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  62 in total

1.  Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.

Authors:  Erik S Musiek; Rebecca S Breeding; Ginger L Milne; Giuseppe Zanoni; Jason D Morrow; Bethann McLaughlin
Journal:  J Neurochem       Date:  2006-04-21       Impact factor: 5.372

Review 2.  Oxidative neuronal injury. The dark side of ERK1/2.

Authors:  Charleen T Chu; David J Levinthal; Scott M Kulich; Elisabeth M Chalovich; Donald B DeFranco
Journal:  Eur J Biochem       Date:  2004-06

3.  Effects of mutant huntingtin on mGluR5-mediated dual signaling pathways: implications for therapeutic interventions.

Authors:  Shan-Shan Huang; Jun He; Dong-Ming Zhao; Xiao-Yuan Xu; Hui-Ping Tan; He Li
Journal:  Cell Mol Neurobiol       Date:  2010-07-20       Impact factor: 5.046

4.  Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase.

Authors:  Li-Jin Chew; William Coley; Ying Cheng; Vittorio Gallo
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

5.  The growth compromised HSV-2 mutant DeltaRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures.

Authors:  Michael D Gober; Jennifer M Laing; Scott M Thompson; Laure Aurelian
Journal:  Brain Res       Date:  2006-10-03       Impact factor: 3.252

Review 6.  Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

Authors:  Ruben K Dagda; Jianhui Zhu; Charleen T Chu
Journal:  Mitochondrion       Date:  2009-06-27       Impact factor: 4.160

7.  D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis.

Authors:  Jumpei Sasabe; Tomohiro Chiba; Marina Yamada; Koichi Okamoto; Ikuo Nishimoto; Masaaki Matsuoka; Sadakazu Aiso
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

8.  The herpes simplex virus type 2 gene ICP10PK protects from apoptosis caused by nerve growth factor deprivation through inhibition of caspase-3 activation and XIAP up-regulation.

Authors:  Samantha Q Wales; Baiquan Li; Jennifer M Laing; Laure Aurelian
Journal:  J Neurochem       Date:  2007-10       Impact factor: 5.372

Review 9.  The Role of PI3K/Akt and ERK in Neurodegenerative Disorders.

Authors:  Sachchida Nand Rai; Hagera Dilnashin; Hareram Birla; Saumitra Sen Singh; Walia Zahra; Aaina Singh Rathore; Brijesh Kumar Singh; Surya Pratap Singh
Journal:  Neurotox Res       Date:  2019-02-01       Impact factor: 3.911

10.  The effect of angiotensin II and IV on ERK1/2 and CREB signalling in cultured rat astroglial cells.

Authors:  Adam Holownia; Jan J Braszko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.